The Valley Desk

NCT03597581 · Interventional trial

A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer

Overall registry status Completed

Phase 1

Conditions CRC, Colorectal Cancer, Colorectal Cancer Metastatic, Colorectal Carcinoma, Colorectal Neoplasms, Gastric Cancer, Gastric Neoplasm, Gastrointestinal Cancer, Gastrointestinal Neoplasms, KRAS Mutation-Related Tumors

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov